Analysis of the Effectiveness of Nursing Interventions in Critically Ill Patients in Respiratory Medicine.

Li-Jing Wu,Ping Li,Guo Li,Wen-Wen Jiao,Shun-Jing Wang,Huan-Huan Wang,Bhagyaveni M.A

doi:10.1155/2022/1193282

Abstract

Objective To enhance and analyze the clinical effectiveness of implementing quality nursing interventions in the clinical care of critically ill patients in respiratory medicine. Methods Clinical data of respiratory medicine patients treated in our hospital over the years were collected and 96 patients who met the requirements of the purpose of this study and the sample inclusion criteria were selected as the study subjects from the patients treated between April 2019 and January 2020. According to the care methods received by the patients in our hospital, 48 of them who implemented conventional care were used as the control group, and another 48 patients who were given quality care interventions were used as the observation group. The data were statistically recorded and comparatively analyzed for the indicators such as nursing oxygen index, heart rate, and clinical treatment efficiency of patients in both groups. Results Compared with the control group, patients in the observation group who received quality nursing intervention had more significant improvement in blood oxygen index and heart rate after nursing care; the clinical treatment efficiency of patients in the observation group was significantly higher than that of the control group (95.83% vs. 81.25%). The data comparison between the groups showed a significant difference, P < 0.05, which was statistically significant. Conclusion Adding quality nursing interventions to the implementation of conventional care for patients with respiratory diseases can better improve patients' clinical symptoms, accelerate their clinical recovery, improve and enhance prognosis, and further improve clinical outcomes.

Highlights

Since the outbreak in December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 151 million people worldwide
More than 3.1 million people died from the 2019 coronavirus disease (COVID-19), which is caused by SARS-CoV-2. e virus mainly affects the upper respiratory tract and lungs, causing pneumonia of varying severity
There was no significant difference in heart rate and respiratory rate between the two groups (P > 0.05); after care, the heart rate (80.25 ± 8.41 beats/min) and respiratory rate (22.05 3.21 beats/min) in the observation group were better than the control group; there was a significant difference (P < 0.05) (Tables 2∼3)

Summary

Introduction

Since the outbreak in December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 151 million people worldwide. More than 3.1 million people died from the 2019 coronavirus disease (COVID-19), which is caused by SARS-CoV-2. E virus mainly affects the upper respiratory tract and lungs, causing pneumonia of varying severity. Since 2021, new variants of the new coronavirus severe acute respiratory syndrome have emerged rapidly, from an outbreak to a global pandemic [1]. E global incidence of respiratory diseases and complications is increasing. E method was to ventilate the critically ill patients in the prone position, but it would bring adverse consequences such as skin damage [3].

Methods

Results

Conclusion